Compare: EMR vs WYNN - An Analysis of Trends, Performance, and Earnings
Compare: Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA) 7.76% EMR vs 6.84% for WYNN
When analyzing the financial markets, comparing specific trading strategies or specific stocks can provide insightful perspectives. Here, we'll conduct a comparative analysis of two stocks: Emerson Electric Co. (EMR) in the Industrial Machinery industry and Wynn Resorts, Limited (WYNN) in the casino/Gaming industry. We'll juxtapose these two stocks under two different strategies, namely, "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" for EMR, and "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" for WYNN.
Price Growth Comparison
In terms of price growth, EMR witnessed a rise of 1.88% this week, compared to WYNN, which saw a higher uptick of 2.75% during the same period. It is worth noting that both stocks outperformed their respective industry averages for the week. The average weekly price growth across all stocks in the Industrial Machinery industry was a decline of 0.68%, while the casino/Gaming industry saw a slight decrease of 0.37%.
From a broader perspective, over the last month, the Industrial Machinery industry rebounded with an average growth of 4.13%. On the other hand, the casino/Gaming industry experienced marginal growth, averaging 0.39%. On a quarterly basis, both industries observed a strong positive trend, with the Industrial Machinery industry posting an average growth of 13.74%, while the Casinos/Gaming industry exceeded this with a growth of 16.84%.
Strategy Returns Comparison
When we observe the returns of the respective strategies, we notice that the 'Trading in Markets Trending Down' strategy yielded a 7.76% return for EMR, while the 'Trading in Markets Trending Up' strategy for WYNN resulted in a slightly lower return of 6.84%. This indicates that EMR's swing trading strategy performed slightly better in a downward-trending market, compared to WYNN's performance in an upward-trending market.
Both EMR and WYNN are scheduled to report their earnings on August 8, 2023. The release of these reports is a key event for investors as it gives a clear snapshot of the financial health and operational performance of the companies.
While WYNN experienced a greater weekly price growth, the Swing Trader strategy for EMR in a downward trending market produced better returns. However, the industry growth trend and the upcoming earnings reports can potentially sway the scales. Thus, investors are advised to keep these factors in mind while making investment decisions.
EMR saw its Momentum Indicator move above the 0 level on September 14, 2023. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMR advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 278 cases where EMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for EMR moved out of overbought territory on September 12, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where EMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for EMR turned negative on September 13, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
EMR broke above its upper Bollinger Band on August 25, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. EMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.759) is normal, around the industry mean (12.478). P/E Ratio (17.699) is within average values for comparable stocks, (44.967). EMR's Projected Growth (PEG Ratio) (3.607) is slightly higher than the industry average of (2.031). Dividend Yield (0.021) settles around the average of (0.021) among similar stocks. P/S Ratio (2.767) is also within normal values, averaging (10.726).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of process controls systems, valves and analytical instruments
A.I.dvisor indicates that over the last year, EMR has been closely correlated with IR. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if EMR jumps, then IR could also see price increases.